默沙东的Enlicitide Decanoate,一个正在研发的口服Pcsk9抑制剂,在第三阶段Coralreef Lipids试验中显著降低了Ldl-C。
默沙东的Enlicitide Decanoate,一个正在研发的口服Pcsk9抑制剂,在第三阶段Coralreef Lipids试验中显著降低了Ldl-C。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.